Improving Outcomes in Patients With RVO: Tailoring Treatment

This program of online webcasts with downloadable slides compiles findings from recent clinical trials and studies, highlighting differences among anti-VEGF therapies for RVO and describing treatment protocols that include optimal treatment sequencing and anti-VEGF injection intervals and strategies for long-term management in patients who do not respond well to first-line therapy.

Share

Program Content

Activities

RVO
Improving Outcomes in Patients With RVO: Tailoring Treatment
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 15, 2023

Expires: November 14, 2024

View Activity

Activities

Tailoring Treatment in RVO
Improving Outcomes in Patients With RVO: Tailoring Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 03, 2023

View Activity

Faculty

cover img faculity

Carl J. Danzig, MD

Director of Vitreoretinal Services and Retina Clinical Research
Rand Eye Institute
Deerfield Beach, Florida
Affiliate Assistant Professor of Clinical Biomedical Science
Charles E. Schmidt College of Medicine
Florida Atlantic University
Boca Raton, Florida

cover img faculity

Arshad M. Khanani, MD, MA, FASRS

Managing Partner
Director of Clinical Research
Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada
Reno, Nevada

cover img faculity

Ashleigh Levison, MD

Partner Physician
Colorado Retina Associates
Denver, Colorado 

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc